Card image cap

Tim Ryan's Public Statements on Issue: Drugs

2

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
04/13/2021 Letter to the Hon. Nora Volkow, Director of the National Institute on Drug Abuse - Latta Leads Bipartisan Letter to Help Improve Outcomes for Americans Struggling with Addiction
06/06/2020 Letter to Hon. Chad Wolf, Acting Secretary of the Department of Homeland Security - Congressmen Norcross, Chabot Lead Call for Release of Appropriated Funds for U.S. Coast Guard National Security Cutter
09/19/2019 Letter to the Hon. Ned Sharpless, Acting Commissioner U.S. Food and Drug Administration - Pingree Leads Bipartisan Letter to FDA Urging Legal Pathway for CBD
01/09/2019 Letter to the Hon. Nancy Pelosi and the Hon. Steny Hoyer - Make Opioid Treatment a Top Priority Next Congress
01/09/2019 Letter to the Hon. Nancy Pelosi, Speaker of the House, and the Hon. Steny Hoyer, House Majority Leader - Blunt Rochester Calls on House Leadership to Commit Additional Resources to Opioid & Addiction Treatment in the 116th Congress
05/22/2018 Letter to President Donald Trump - Maintain the Fight Against Drug Trafficking
02/02/2018 Letter to the Honorable Paul Ryan, Speaker of the House of Representatives, the Honorable Nancy Pelosi, House Minority Leader, the Honorable Rodney Frelinghuysen, Chairman and the Honorable Nita Lowey, Ranking Member of House Appropriations Committee - Include Opioid Crisis Emergency Funding in Next Government Funding Bill
01/19/2018 Letter to the Hon. Donald J. Trump, President of the United States - Declare Opioid Epidemic a National Emergency
01/19/2018 Letter to President Donald Trump - Bipartisan Heroin Task Force Urges President to Renew Public Health Emergency Declaration and Provide Adequate Funding
12/11/2017 Letter to the Hon. Mick Mulvaney, Director of Office of Management and Budget - Additional Federal Opioid Relief
11/30/2017 Letter to John Kasich, Governor of Ohio - Increase Drug Chemistry Unit Lab Funding
08/22/2017 Letter to the Hon. Donald J. Trump, President - Implementation of Opioid Commission Recommendations
08/09/2017 Letter to President Donald Trump - Declare a National Emergency Over Opioid Epidemic
08/08/2017 Letter to President Donald J. Trump - Kuster Leads Letter to President Trump Calling for Action on the Opioid Epidemic
05/16/2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
05/03/2017 Letter to Dr. Margaret Chan, Director of the World Health Organization - Stop a Worldwide Opioid Epidemic
02/21/2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike
01/27/2017 Letter to Congressman Price - Rep. Jenkins Asks HHS Nominee to Budget for NAS Treatment
11/21/2016 Letter to the Hon. Paul Ryan, Speaker of the House, and the Hon. Mitch McConnell, Majority Leader of the U.S. Senate - Funding to Combat Heroin and Opioid Addiction
11/18/2016 Letter to the Honorable Paul Ryan, Speaker of the U.S. House of Representatives and the Honorable Mitch McConnell, Majority Leader of the U.S. Senate - Call for Funding to Combat Drug Epidemic
09/13/2016 Letter to the Honorable Paul Ryan, Speaker of the House and the Honorable Nancy Pelosi, Minority Leader of the House - Calling for Budget Anomalies to Address Opioid Epidemic
05/04/2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic
07/31/2014 Letter to Shaun Donovan, Director of the Office of Management and Budget - Offering Safe Prescription Drug Disposal Options
04/23/2014 Letter to Margaret Hamburg, Commissioner of the United States Food and Drug Administration - Recognize Naloxene as a Safe and Effective Opioid Overdose Reversal Drug for Over-the-Counter Use
12/12/2007 Letter to House Energy and Commerce Committee
arrow_upward